We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for formulation.
ipros is IPROS GMS IPROS One of the largest technical database sites in Japan that collects information on.

formulation Product List and Ranking from 40 Manufacturers, Suppliers and Companies

Last Updated: Aggregation Period:Aug 13, 2025~Sep 09, 2025
This ranking is based on the number of page views on our site.

formulation Manufacturer, Suppliers and Company Rankings

Last Updated: Aggregation Period:Aug 13, 2025~Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. シーシーアイ Gifu//Chemical 住設・建材事業部 営業部
  2. null/null
  3. ハイペロン Okayama//others
  4. 4 小松マテーレ Ishikawa//fiber
  5. 5 三泰産業 Hiroshima//Chemical 本社

formulation Product ranking

Last Updated: Aggregation Period:Aug 13, 2025~Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. 【Technical Data】Grease-decomposing Microbial Agent 'Oil Varnish' シーシーアイ 住設・建材事業部 営業部
  2. Sodium bicarbonate formulation "Acrecia" for flue gas neutralization treatment for incinerators.
  3. Antioxidant formulation "Ami-21 Pro Tuna" ハイペロン
  4. 4 Sludge volume reduction bio-agent "Veriformer" 小松マテーレ
  5. 5 Ethanol preparation "Esmeel WK II" 三泰産業 本社

formulation Product List

226~238 item / All 238 items

Displayed results

[Research Material] Global Market for Wound Care Biologics

World Market for Wound Care Biologics: Biological Skin Substitutes, Enzyme-Based Products, Growth Factors, Acute Wounds, Chronic Wounds, Surgical Wounds

This research report (Global Wound Care Biologics Market) investigates and analyzes the current status and outlook for the global market of wound care biologics over the next five years. It includes information on the overview of the global wound care biologics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include biological skin substitutes, enzyme-based products, and growth factors, while the segments by application focus on acute wounds, chronic wounds, and surgical wounds. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of wound care biologics. It also includes the market share of major companies in the wound care biologics sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Atropine Sulfate

World Market for Atropine Sulfate: Injection, Drops, Gel, Gastrointestinal, Ophthalmic, Others

This research report (Global Atropine Sulfate Market) investigates and analyzes the current status and outlook for the global atropine sulfate market over the next five years. It includes information on the overview of the global atropine sulfate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments by type in the atropine sulfate market focus on injections, drops, and gels, while the segments by application cover gastrointestinal, ophthalmic, and others. The regional segments calculate the market size of atropine sulfate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the atropine sulfate market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

【Research Material】Global Market for Local Antibiotic Preparations

Global Market for Local Antibiotic Preparations: Ointments, Creams, Suspensions, Powders, Hospital Clinics, Private Clinics, Retail Pharmacies/Drugstores, E-commerce

This research report (Global Topical Antibiotic Pharmaceuticals Market) investigates and analyzes the current state and outlook for the global market of topical antibiotic formulations over the next five years. It includes information on the overview of the global topical antibiotic formulations market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include ointments, creams, suspensions, and powders, while the segments by application cover hospital clinics, private clinics, retail pharmacies and drugstores, and e-commerce. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of topical antibiotic formulations. It also includes the market share of major companies in topical antibiotic formulations, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Hyaluronic Acid Products

Global Market for Hyaluronic Acid Products: Single Cycle Injection Products, 3 Cycle Injection Products, 5 Cycle Injection Products ...

This research report (Global Hyaluronic Acid Products Market) investigates and analyzes the current status and outlook for the global market of hyaluronic acid products over the next five years. It includes information on the overview of the global hyaluronic acid products market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include single-cycle injection products, three-cycle injection products, and five-cycle injection products, while the segments by application cover osteoarthritis, ophthalmology, dermal fillers, and bladder-ureteral reflux. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of hyaluronic acid products. The report also includes the market share of major companies in hyaluronic acid products, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Gelling agent formulation "MCG Series"

Cost reduction. Supports heated sterilization jelly, chilled jelly, and drink jelly.

The "MCG Series" is a gelling agent formulation that does not use locust bean gum. "MCG-1" has high transparency and moderate viscosity, while "MCG-2" is colorless and odorless, allowing for various arrangements. Additionally, "MCG-3" offers the unique freshness and texture characteristic of agar. We also accept requests for the development of custom gelling agent formulations for your company, so please feel free to consult with us. 【Features】 ■MCG-1 - Can be heat sterilized at 85°C for 30 minutes ■MCG-2 - Has a pleasant, elastic texture *For more details, please download the PDF or feel free to contact us.

  • Gelling Agent

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Sludge volume reduction bio-agent "Veriformer"

It is possible to achieve zero generation of surplus sludge. Significantly reduce the sludge treatment costs in wastewater treatment. There is a track record of reducing 4,300 tons of surplus sludge in just five months.

The sludge reduction bio-agent "Veriformer" is a product that can significantly reduce excess sludge generated from activated sludge treatment using microorganisms. By retaining only the necessary amount of microorganisms for wastewater treatment, it can reduce up to 100% of excess sludge, thereby eliminating costs associated with waste disposal and sludge dewatering. 【Features】 ■ Enables efficient reduction of sludge ■ Significantly reduces waste disposal costs ■ Can be used with zero equipment investment *For more details, please refer to the materials. Feel free to contact us as well.

  • Wastewater/wastewater treatment equipment

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Monochloramine preparation "Flip-Flap"

Easy and inexpensive measures against Legionella! A monochloramine disinfection method that can be used easily without the need for equipment.

"Flip-Flap" is a revolutionary invention by Dr. Hideyuki Seki, who has researched chlorine disinfection for many years. It is a monochloramine disinfection method devised from the understanding of the breeding mechanisms of Legionella bacteria, which can be easily used without the need for special equipment. By regularly applying it according to the instructions, biofilms are detached, reattachment is prevented, and the activity of amoebas, which are factors in the proliferation of Legionella bacteria, is halted. Using this product as a substitute for high-concentration chlorine disinfection allows for excellent biofilm management. Additionally, disinfection can be performed simply by sprinkling this product into the bathtub, and the circulated water with the product added can be used without disposal, enabling significant cost savings. 【Features】 - Biofilms are detached and reattachment is prevented - Activity of amoebas is halted - Usable in alkaline hot springs - Safe and secure - Cost reduction *For more details, please refer to the catalog or feel free to contact us.

  • Other quality control and hygiene measures
  • Fungicides

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

【BV4 Features】Safety and Security <Disinfectant OEM>

Safe to use even in food handling environments! It can be stored for a long time as it is less likely to deteriorate.

We would like to introduce the features of the antiviral and antibacterial agent "BV4," focusing on its "safety and security." This product is composed entirely of "food and food additives," making it safe to use in environments that handle food. Additionally, it has low irritability and does not harm the skin. It is less likely to damage fabrics such as clothing and is resistant to discoloration. It also has a low risk of causing metal corrosion, making it suitable for hygiene management of cooking utensils and machinery. Due to its resistance to degradation from volatilization, it can be stored for long periods. 【Features (Details)】 ■ Harmless to humans ■ Considerate of the skin ■ Harmless to clothing, metals, plastics, and rubber products ■ Easy to manage *For more details, please refer to the related links or feel free to contact us.

  • Fungicides

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

【BV4 Features】Effect against Coronavirus <Disinfectant OEM>

The effectiveness against the SARS coronavirus (official name SARS-CoV) has been confirmed!

The antiviral and antibacterial agent "BV4" has features such as "effectiveness against coronaviruses." Its effectiveness against the SARS coronavirus (officially known as SARS-CoV) has been confirmed. Additionally, it boasts 100% antiviral and antibacterial power, as well as high mold prevention capabilities. Please feel free to contact us if you have any inquiries. 【Other Features】 ■ Safe and secure ■ 100% antiviral and antibacterial power ■ High mold prevention capability (effectiveness against mold) ■ Effectiveness against avian influenza virus ■ Low odor effect *For more details, please refer to the related links or feel free to contact us.

  • Fungicides

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Biologics Market Report: 2025-2035

The increasing demand for biopharmaceuticals accelerates market growth.

The growing demand for biopharmaceuticals continues to be a major driving force behind the growth of the pharmaceutical market as of 2025. Biologics, which are derived from living organisms, are known for their high precision in targeting specific molecules or cells, leading to effective treatments with reduced side effects. This high level of precision is particularly useful in addressing complex conditions such as cancer, autoimmune diseases, and rare genetic disorders. Recent advancements are expanding the therapeutic applications of biopharmaceuticals. For example, in December 2024, the U.S. Food and Drug Administration approved the IL-31 inhibiting biologic Nemluvio (nemolizumab-ilto), developed by Galderma, for patients aged 12 and older with moderate to severe atopic dermatitis. This approval introduces a new option for managing this chronic skin condition. 【Contents】 ■ Market Overview ■ Market Analysis (Product Type, Application, Manufacturing Type, Source, End User) ■ Regional Market Analysis ■ Company Profiles

  • Other bio-related products and services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Oral Solid Dosage Forms

World Market for Oral Solid Dosage Forms: Immediate Release, Extended Release, Others, Hospital Pharmacies, Retail Pharmacies, Drugstores, Others

This research report (Global Oral Solid Dosage Pharmaceutical Formulation) investigates and analyzes the current state of the global oral solid dosage formulation market and its outlook for the next five years. It includes information on the overview of the global oral solid dosage formulation market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the oral solid dosage formulation market include immediate release, extended release, and others, while the segments by application cover hospital pharmacies, retail pharmacies, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of oral solid dosage formulations. It also includes the market share of major companies in oral solid dosage formulations, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Hospital Formulations

Global Market for Hospital Formulations: Antihypertensives, Dyslipidemia Drugs, Alkylating Agents, Antimetabolites, Hormones, Immunomodulators, Other Drugs, Anxiolytics, Antimigraine ...

This research report (Global Hospital Pharmaceuticals Market) investigates and analyzes the current state of the global hospital pharmaceuticals market and its outlook for the next five years. It includes information on the overview of the global hospital pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antihypertensives, dyslipidemia drugs, alkylating agents, antimetabolites, hormones, immunomodulators, other drugs, anxiolytics, antimigraine drugs, and antidepressants. The segments by application focus on cardiovascular diseases, tumors, kidney diseases and urology, neurology, pain, and infectious diseases. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of hospital pharmaceuticals. It also includes the market share of major companies in the hospital pharmaceuticals sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Acetic Acid Trenbolone

World Market for Acetate Trenbolone: Androgen Alone, Combination Formulations, Cattle, Others

This research report (Global Trenbolone Acetate (CAS 10161-34-9) Market) investigates and analyzes the current status and outlook for the global trenbolone acetate market over the next five years. It includes information on the overview of the global trenbolone acetate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the trenbolone acetate market focus on androgen alone and combination formulations, while the segments by application target cattle and others. The regional segments calculate the market size of trenbolone acetate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the trenbolone acetate market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration